Lyv

Lyv is a precision oncology company that provides a clinical decision support platform designed to democratize access to personalized cancer treatments. Founded by world-renowned oncologists, the company leverages a proprietary database and AI-driven insights to match patients with targeted therapies and clinical trials based on their unique genomic profiles. Lyv's platform facilitates collaboration between patients, oncologists, and payers to optimize treatment outcomes and reduce healthcare costs. The company focuses on integrating real-world evidence with molecular data to guide complex clinical decisions in oncology, particularly for patients with rare or hard-to-treat cancers. By streamlining the interpretation of complex molecular profiles, Lyv enables personalized treatment plans that are tailored to the specific biology of an individual's tumor.